Stock Price Quote

AHLCON PARENTERALS (INDIA) LTD.

NSE : NABSE : 524448ISIN CODE : INE027C01011Industry : Pharmaceuticals & DrugsHouse : Ahlcon Parenterals - MNC
BSE515.000 (0 %)
PREV CLOSE ( ) 515.00
OPEN PRICE ( ) 515.00
BID PRICE (QTY) 515.00 (2000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29501
TODAY'S LOW / HIGH ( )514.75 516.75
52 WK LOW / HIGH ( ) 514.75517.25
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1992
Management Info
Andreas Walde - Chairman Indranil Mukherjee - Managing Director
Registered Office

Address Plot No. 30 & 30 E,2 Floor, Shivaji Marg,Najafgarh Road Industrial Area,
New Delhi,
Delhi-110015

Phone 011– 42344234

Email ranjan.sahu@ahlconindia.com

Website www.ahlconindia.com

Registrars Details
MAS Services Ltd
T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi
Listing : BSE, Delhi, Jaipur, Kolkata

NEWS

18Nov Ahlcon Parenterals (India) submits dis
Ahlcon Parenterals (India) has submitted the disclosures under Reg.13(6)..
14Nov Ahlcon Parenterals (India) informs abo
Ahlcon Parenterals (India) has informed about the Standalone Financial R..
28Oct Ahlcon Parenterals (India) informs abo
Ahlcon Parenterals (India) has submitted a copy of the proceeding of the..
22Aug Ahlcon Parenterals (India) fixes Book
Ahlcon Parenterals (India) has informed that the Register of Members &am..
15May Ahlcon Parenterals to commence commerc
Ahlcon Parenterals (India) has initiated programme for expansion of capa..

Financials

in Millions
QTR Dec 14 ANNUAL 14
Net Profit65.45195.04
Gross Profit 77.29 300.63
Operating Profit 88.72350.87
Net Sales 332.031199.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2621.00 (5.75%)
M.Cap ( in Cr)1619.26
Glaxosmithkline Phar (BSE)
peergroup  2079.80 (7.06%)
M.Cap ( in Cr)35233.07
TTK Healthcare (BSE)
peergroup  1591.35 (5.77%)
M.Cap ( in Cr)2248.63
Cipla (BSE)
peergroup  1398.80 (3.79%)
M.Cap ( in Cr)112938.41
Torrent Pharma (BSE)
peergroup  2685.00 (1.85%)
M.Cap ( in Cr)90872.60

Shareholding Pattern

PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
NON-INSTITUTION 0%

About Ahlcon Parenterals (India) Ltd.

Ahlcon Parenterals (India) Ltd. was incorporated in the year 1992. Its today's share price is 515. Its current market capitalisation stands at Rs 370.81 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1756.66 Cr and Total Income of Rs.1802.74 Cr. The company's management includes krzysztof Przemyslaw kolodziejski, Ranjan Kumar Sahu, Gabriel Sabate Parayre, Christopher Mueller, S S Arora, S C L Gupta, Arun Kumar Gupta, Indranil Mukherjee, Andreas Walde.

It is listed on the BSE with a BSE Code of 524448 , NSE with an NSE Symbol of and ISIN of INE027C01011. It's Registered office is at Plot No. 30 & 30 E,2 Floor, Shivaji Marg,Najafgarh Road Industrial AreaNew Delhi-110015, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Arun K Gupta & Associates, Price Waterhouse Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.